Liver dysfunction in Turner's syndrome: Prevalence, natural history and effect of exogenous oestrogen

Clinical Endocrinology

Volumn 69, Issue 2, 2008, Pages 306-310

  Koulouri, Olympia ^a   Ostberg, Julia ^a   Conway, Gerard S ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN; DYDROGESTERONE; DYDROGESTERONE PLUS ESTRADIOL; ESTRADIOL; ESTRADIOL VALERATE; ETHINYLESTRADIOL; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; AUTOIMMUNITY; BILIRUBIN BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER FUNCTION TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TURNER SYNDROME;

ADOLESCENT; ADULT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL CONGENERS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LIVER DISEASES; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; TURNER SYNDROME; YOUNG ADULT;

EID: 47549100662     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03203.x     Document Type: Article

References (17)

1. Sylven, L., Hagenfeldt, K., Brondum-Nielsen, K. von, S.B. (1991) Middle-aged women with Turner's syndrome. Medical status, hormonal treatment and social life. Acta Endocrinologica, 125, 359 365.
2. Salerno, M.M.S., Gasparini, N., Rizzo, M., Ferri, P. Vajro, P. (1999) Liver abnormalities in Turner syndrome. European Journal of Pediatrics, 158, 618 623.
3. Elsheikh, M., Hodgson, H.J., Wass, J.A. Conway, G.S. (2001) Hormone replacement therapy may improve hepatic function in women with Turner's syndrome. Clinical Endocrinology, 55, 227 231.
4. Albareda, M.M., Gallego, A., Enriquez, J., Rodriguez, J.L. Webb, S.M. (1999) Biochemical liver abnormalities in Turner's syndrome. European Journal of Gastroenterology and Hepatology, 11, 1037 1039.
5. Larizza, D., Locatelli, M., Vitali, L., Vigano, C., Calcaterra, V., Tinelli, C., Sommaruga, M.G., Bozzini, A., Campani, R. Severi, F. (2000) Serum liver enzymes in Turner syndrome. European Journal of Pediatrics, 159, 143 148.
6. Gravholt, C.H., Juul, S., Naeraa, R.W. Hansen, J. (1998) Morbidity in Turner syndrome. Journal of Clinical Epidemiology, 51, 147 158.
7. Roulot, D., Degott, C., Chazouilleres, O., Oberti, F., Cales, P., Carbonell, N., Benferhat, S., Bresson-Hadni, S. Valla, D. (2004) Vascular involvement of the liver in Turner's syndrome. Hepatology, 39, 239 247.
8. Gravholt, C.H., Poulsen, H.E., Ott, P., Christiansen, J.S. Vilstrup, H. (2007) Quantitative liver functions in Turner syndrome with and without hormone replacement therapy. European Journal of Endocrinology, 156, 679 686.
9. Ostberg, J.E., Storry, C., Donald, A.E., Attar, M.J., Halcox, J.P. Conway, G.S. (2007) A dose-response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism. Clinical Endocrinology, 66, 557 564.
10. Ostberg, J.E., Thomas, E.L., Hamilton, G., Attar, M.J., Bell, J.D. Conway, G.S. (2005) Excess visceral and hepatic adipose tissue in Turner syndrome determined by magnetic resonance imaging: estrogen deficiency associated with hepatic adipose content. Journal of Clinical Endocrinology and Metabolism, 90, 2631 2635.
11. Guttmann, H., Weiner, Z., Nikolski, E., Ish-Shalom, S., Itskovitz-Eldor, J., Aviram, M., Reisner, S. Hochberg, Z. (2001) Choosing an oestrogen replacement therapy in young adult women with Turner syndrome. Clinical Endocrinology, 54, 159 164.
12. Shimizu, I., Kohno, N., Tamaki, K., Shono, M., Huang, H.W., He, J.H. Yao, D.F. (2007) Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection. World Journal of Gastroenterology, 28, 4295 4305.
13. McKenzie, J., Fisher, B.M., Jaap, A.J., Stanley, A., Paterson, K. Sattar, N. (2006) Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. Clinical Endocrinology, 65, 40 44.
14. Bruno, S., Maisonneuve, P., Castellana, P., Rotmensz, N., Rossi, S., Maggioni, M., Persico, M., Colombo, A., Monasterolo, F., Casadei-Giunchi, D., Desiderio, F., Stroffolini, T., Sacchini, V., Decensi, A. Veronesi, U. (2005) Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial. British Medical Journal, 23, 932.
15. Nemoto, Y., Toda, K., Ono, M., Fujikawa-Adachi, K., Saibara, T., Onishi, S., Enzan, H., Okada, T. Shizuta, Y. (2000) Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. Journal of Clinical Investigations, 105, 1819 1825.
16. Toth, M.J., Sites, C.K. Matthews, D.E. (2006) Role of ovarian hormones in the regulation of protein metabolism in women: effects of menopausal status and hormone replacement therapy. American Journal of Physiology - Endocrinology and Metabolism, 291, E639 E646.
17. Duvnjak, M., Lerotic, I., Barsic, N., Tomasic, V., Virovic, J.L. Velagic, V. (2007) Pathogenesis and management issues for non-alcoholic fatty liver disease. World Journal of Gastroenterology, 14, 4539 4550.